guidewire secured across the narrowing, in a target vessel with tortuosity or excessive angulation, it may not be possible to pass the catheter distally; (3) adequate systolic blood pressure (>80 mm Hg) is required; and (4) the catheter is predisposed to thrombotic occlusion, owing to relative stagnation of flow and the likelihood of preexisting intraluminal fibrin at the time of insertion. Thus, the current state of the art of failed coronary angioplasty management can be summarized as the use of empiric strategies that have limited effectiveness for sustaining target vessel patency, frequently resulting in emergency backup surgical revascularization.
Quite recently, several innovative methods have been developed and preliminary clinical evaluation of most of these is currently underway. Although many of these methods were originally designed to address restenosis, there is more imminent potential for some to deal with abrupt closure. These new approaches can be categorized as either direct or indirect coronary artery methods.
Of the direct approaches, the autoperfusion dilatation catheterlO is similar to the bail out catheter but the balloon allows very prolonged inflation, which anecdotally has reduced the need for emergency bypass surgery. The endoluminal stent,"J2 which has also been developed to reduce restenosis, may find its place in the establishment of sustained patency after abrupt closure. To date, Sigwart has deployed a stent in 19 cases of "refractory" closure, without incident or need for bypass surgery (Ulrich Sigwart, personal communication). Laser "welding" of the dissected intimal segment represents another alternative that has proved useful in experimental studies and has just begun clinical testing for abrupt closure.13J4 It is likely that other forms of "pyroplasty" such as electrical or radiofrequency energy sources may be equally effective for this purpose. Recently, the Simpson atherectomy device has been used to excise intimal flaps and it too has potential as a direct intervention in this setting.
Besides intraaortic balloon counterpulsation, which has frequently been used for intractable abrupt closure, 2 new indirect percutaneous interventions are being assessed. The back door perfusion approach is the coronary sinus, and 2 different methods-synchronized retroperfusion or intermittent balloon occlusion-have been tested.15J6 It has not yet been established whether coronary sinus interventions will restore adequate myocardial perfusion in patients. A promising indirect intervention is percutaneous femoral-femoral cardiopulmonary bypass. If this can be quickly and reliably initiated, systemic perfusion is ensured and marked unloading of the left ventricle leads to a very low myocardial oxygen consumption.17 Although this technique requires surgical femoral vascular repair at the completion of the procedure, and 35,000 U of heparin, it is already being used prophylactically in more than 30 catheterization laboratories in the US (C.R. Bard, Inc., personal communication). This explosive application of percutaneous cardiopulmonary bypass, known as "supported angioplasty", will be the subject of many presentations at next year's national meetings.
These new techniques, however, may engender new problems. First, the "high risk" patient will remain at high risk no matter what new strategy is selected. It will therefore be difficult to objectively evaluate the true benefit of a particular technique and randomization to a control arm is not likely to be feasible in a trial. Second, centers without in-house cardiac surgical resources will increasingly consider the use of one or more of these techniques as a license to practice coronary angioplasty. It is necessary to emphasize that none of the strategies under development is likely to obviate the absolute requirement for backup, emergency surgical revascularization.18 Third, with an array of possible mechanical and pharmacologic approaches, a more tailored and precise scheme will be necessary. The parallel development of flexible coronary angioscopy, providing direct visualization of the diseased segment, is important and may make this possible. Without question, concern and management of abrupt closure after PTCA have plagued patients and operators for many years. With the many new and exciting strategies currently under development, there is a realistic opportunity to markedly improve this procedure.
